757 related articles for article (PubMed ID: 25110000)
1. Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation.
Abo Alrob O; Lopaschuk GD
Biochem Soc Trans; 2014 Aug; 42(4):1043-51. PubMed ID: 25110000
[TBL] [Abstract][Full Text] [Related]
2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
3. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
4. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
5. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling.
Alrob OA; Sankaralingam S; Ma C; Wagg CS; Fillmore N; Jaswal JS; Sack MN; Lehner R; Gupta MP; Michelakis ED; Padwal RS; Johnstone DE; Sharma AM; Lopaschuk GD
Cardiovasc Res; 2014 Sep; 103(4):485-97. PubMed ID: 24966184
[TBL] [Abstract][Full Text] [Related]
6. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
7. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic carnitine acetyltransferase as a source of cytosolic acetyl-CoA: a possible mechanism for regulation of cardiac energy metabolism.
Altamimi TR; Thomas PD; Darwesh AM; Fillmore N; Mahmoud MU; Zhang L; Gupta A; Al Batran R; Seubert JM; Lopaschuk GD
Biochem J; 2018 Mar; 475(5):959-976. PubMed ID: 29438065
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
10. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.
Hall JL; Lopaschuk GD; Barr A; Bringas J; Pizzurro RD; Stanley WC
Cardiovasc Res; 1996 Nov; 32(5):879-85. PubMed ID: 8944819
[TBL] [Abstract][Full Text] [Related]
11. The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart.
Lopaschuk GD; Gamble J
Can J Physiol Pharmacol; 1994 Oct; 72(10):1101-9. PubMed ID: 7882173
[TBL] [Abstract][Full Text] [Related]
12. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
13. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Ussher JR; Lopaschuk GD
Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
Hopkins TA; Dyck JR; Lopaschuk GD
Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart.
Thapa D; Zhang M; Manning JR; Guimarães DA; Stoner MW; O'Doherty RM; Shiva S; Scott I
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H265-H274. PubMed ID: 28526709
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart.
Lopaschuk GD; Witters LA; Itoi T; Barr R; Barr A
J Biol Chem; 1994 Oct; 269(41):25871-8. PubMed ID: 7929291
[TBL] [Abstract][Full Text] [Related]
17. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
Dyck JR; Lopaschuk GD
J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
[TBL] [Abstract][Full Text] [Related]
18. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
Ussher JR; Lopaschuk GD
Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
[TBL] [Abstract][Full Text] [Related]
19. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
20. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
